Narayana Hrudayalaya Q2 FY18 Consolidated operating income at Rs 5,592 million Ruby Khatun Khatun8 Nov 2017 10:07 AM ISTBengaluru: Narayana Hrudayalaya Limited, a leading healthcare service provider in India, announced its financial results for the second quarter (Q2...
Novartis seeks European approval for cell therapy Kymriah Ruby Khatun Khatun8 Nov 2017 9:47 AM ISTZURICH: Swiss drugmaker Novartis has submitted its cell therapy Kymriah for European approval in two forms of blood cancer, seeking to expand the use...
Bayer in bid to broaden use of anti-clotting drug Xarelto Ruby Khatun Khatun8 Nov 2017 9:31 AM ISTFRANKFURT: German drugmaker Bayer on Monday moved to tap a potentially lucrative new market opportunity for its blockbuster clot prevention drug...
Valeant to sell female libido pill business back to former owners Ruby Khatun Khatun8 Nov 2017 9:15 AM ISTValeant Pharmaceuticals International Inc said on Monday it will sell its female libido-pill business Sprout Pharmaceuticals back to its former...
Natco Pharma invests Rs 7.5 crore in Hyderabads PACE Hospital Ruby Khatun Khatun7 Nov 2017 11:42 AM ISTNew Delhi: Natco Pharma said it has invested Rs 7.5 crore to pick up 7.5 percent stake in OMRV Hospitals."NATCO Pharma Ltd would like to announce that...
FDA approves Roche drugs for rare types of blood, lung cancers Ruby Khatun Khatun7 Nov 2017 10:27 AM ISTRoche Holding AG won U.S. approval to market its skin cancer drug Zelboraf for certain patients with Erdheim-Chester Disease, a rare type of blood...
Torrent Pharma gets green nod for Rs 300 crore project Ruby Khatun Khatun7 Nov 2017 10:08 AM ISTThe Centre gave the green nod to Torrent Pharmaceuticals' proposal to establish a bulk drug manufacturing unit in Gujarat with an investment of Rs 300...
Takeda takes on Sanofi with new global dengue vaccine data Ruby Khatun Khatun7 Nov 2017 10:07 AM ISTTakeda Pharmaceutical's experimental dengue vaccine has produced promising long-term results in clinical tests, boosting the Japanese company's global...
Johnson and Johnson Stelara shows promise against lupus in study Ruby Khatun Khatun7 Nov 2017 9:47 AM ISTJohnson and Johnson’s blockbuster psoriasis drug Stelara led to a significant reduction in disease activity in patients with systemic lupus compared...
Former GSK boss to lead new UK accelerated drug access scheme Ruby Khatun Khatun7 Nov 2017 9:30 AM ISTLONDON: Former GlaxoSmithKline (GSK) boss Andrew Witty is to lead a new British scheme to accelerate access to ground-breaking medicines for...
Regency Healthcare to invest Rs 450 crore to open 3 hospitals Ruby Khatun Khatun6 Nov 2017 12:49 PM ISTNew Delhi: Kanpur-based Regency Healthcare is planning to open three hospitals by the end of 2019 at an investment of Rs 450 crore, a senior company...
Syngene International draws up 102 million dollars spending programme Ruby Khatun Khatun6 Nov 2017 10:02 AM ISTMumbai: Leading contract research and manufacturing organization Syngene International Ltd said it will invest USD 102 million to build new...
